148550-16-7 Usage
Molecular structure
The compound consists of an imidazole ring fused to a carboxylic acid group, a 4-chloro-1-[(4-aminophenyl)methyl]-2-butyl moiety, and a methyl ester group.
Functional groups
Imidazole ring, carboxylic acid, amino group, phenyl group, chloro group, and methyl ester group.
Molecular weight
321.79 g/mol
Applications
Potential use in medicinal chemistry and drug discovery due to its structural features and multiple functional groups.
Synthesis
The compound can serve as a valuable building block for the synthesis of diverse organic molecules and pharmaceuticals.
Further research
Additional research and characterization could reveal its potential as a therapeutic agent or as an intermediate in the production of other valuable chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 148550-16-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,8,5,5 and 0 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 148550-16:
(8*1)+(7*4)+(6*8)+(5*5)+(4*5)+(3*0)+(2*1)+(1*6)=137
137 % 10 = 7
So 148550-16-7 is a valid CAS Registry Number.
148550-16-7Relevant academic research and scientific papers
Nonpeptide angiotensin II receptor antagonists. 1. Synthesis and in vitro structure-activity relationships of 4[[[(1H-pyrrol-1- ylacetyl)amino]phenyl]methyl]imidazole derivatives as angiotensin II receptor antagonists
Sircar,Winters,Quin III,Lu,Major,Panek
, p. 1735 - 1745 (2007/10/02)
A novel series of non-biphenylyltetrazole angiotensin II receptor antagonists which contain a 1H-pyrrol-1-ylacetyl residue in place of the benzoyl residue in EXP 6803 have been developed. The receptor binding activity of several members of this new series
